Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Heredi |
RCV000204423 | SCV000259199 | pathogenic | Alpha-1-antitrypsin deficiency | 2015-08-17 | criteria provided, single submitter | research | |
Counsyl | RCV000204423 | SCV000485961 | likely pathogenic | Alpha-1-antitrypsin deficiency | 2016-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000204423 | SCV001585169 | pathogenic | Alpha-1-antitrypsin deficiency | 2024-06-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln180*) in the SERPINA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERPINA1 are known to be pathogenic (PMID: 25425243). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with alpha-1 antitrypsin deficiency (PMID: 31307431). This variant is also known as Q156X. ClinVar contains an entry for this variant (Variation ID: 219364). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000204423 | SCV004203118 | pathogenic | Alpha-1-antitrypsin deficiency | 2023-10-04 | criteria provided, single submitter | clinical testing |